Skip to main content

Diabetes Type 2

This study is currently active

Type 2 Diabetes is a chronic condition that affects the way the body processes blood sugar (glucose). There’s no cure for type 2 diabetes, but you may be able to manage the condition by eating well, exercising and maintaining a healthy weight. If diet and exercise aren’t enough to manage your blood sugar well, you also may need diabetes medications or insulin therapy.

At Northern California Research we are conducting a study for a new medication to manage type 2 diabetes.

The study will compare Gan & Lee Pharmaceuticals Insulin Glargine Injection to Lantus (Insulin Glargine Injection) in adult subjects with type 2 diabetes.

The study includes 13 visits to the clinic over a 52-week period. Subjects with a confirmed diagnosis of type 2 diabetes mellitus who meet one of the following:

  1. Insulin-naïve and on at least 2 approved oral antidiabetic medications, and the clinician has decided to add insulin therapy
  2. If already being treated with a basal insulin, subjects should have been treated with insulin for at least 6 months in addition to at least 1 approved oral diabetic medication.
  3. HbA1c values as follows:
    1. If insulin-naïve, HbA1c ≤ 11.0%
    2. If previously on a basal insulin regimen, HbA1c ≥7.0% and ≤ 11.0%

No cost for physical exams, diabetic supplies such as lancets and insulin needles, medication, ECG’s, close monitoring of sugars and lab testing.

Compensation for participation: $650

Please refer to this study by its identifier (NCT number): NCT03371108

Participate in a Study

Submit the form and a clinical study expert will get in touch with you.

Want to know more about our clinical trials?